LEARNING OBJECTIVES

 

At the conclusion of this activity, participants will be able to:

 

  1. Explore the risk of associated CVD with autoimmune conditions, focusing on rheumatological conditions
  2. Discussion of potential equation adjustments based on rheumatological conditions
  3. Brief review of 2019 ACC/AHA primary prevention of ASCVD
Session date: 
04/25/2023 - 8:30am to 9:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Macklin, M.D., Pharm. D.